HSPB1 and non-small cell lung carcinoma: The threshold of serum HSP27 mRNA for distinguishing NSCLC patients from benign lung diseases was defined as 25.4 (2−ΔΔCt), responding a sensitivity of 94.76% and specificity of 81.58% (Table 4).